Zandra K. Klippel, MDDr. Zandra Klippel treats patients with multiple myeloma, amyloidosis, MGUS, plasmacytoma, and Waldenstrom’s macroglobulinemia.
Patient Care Philosophy:
I believe in developing a partnership with my patients and their caregivers. Using the latest knowledge in disease biology and treatment, I hope to provide personalized therapy that incorporates state-of-the art clinical trials available at our institution.
Dr. Klippel's Resume
- Researcher, Fred Hutchinson Cancer Research Center
Clinical ExpertisePlasma cell disorders including multiple myeloma, Waldenstrom’s macroglobulinemia, amyloidosis, and monoclonal gammopathy of undetermined significance (MGUS)
Education And Training
- Medical Education: Universidad Mayor de San Simon
- Residency: Mount Auburn Hospital
- Fellowship: University of Washington/Fred Hutchinson Cancer Research Center
Dr. Klippel's Story
Dr. Zandra Klippel believes in developing a partnership with her patients and their caregivers. “Using the latest knowledge in disease biology and treatment, I hope to provide a personalized therapy that incorporates state-of-the art clinical trials available at our institution,” she says.
Dr. Klippel became a doctor because “medicine is a perfect amalgam of art and science,” she says. “As a doctor, you have the honor to be present and share critical moments of peoples’ lives while serving as an advocate for their wellbeing.”
One of her patient's husbands described Dr. Klippel as being "blessed with deep compassion and empathy for her patients, an ability to go well beyond symptoms and treatments..." and that she has the ability to "find the whole patient. She is also a gifted researcher," he writes, "spending her non-clinic hours working on emergent therapies for myeloma that will, we hope, extend the lives of many future patients."
Drl. Klippel's interest in caring for cancer patients is twofold. She says, “First, the diagnosis of cancer affects an individual and his/her family in a way that only a few diseases do. It is a privilege to be part of a team of people that tends to the medical needs of cancer patients and their families. Second, oncology is a specialty within medicine that has benefited greatly from scientific advancement.”
While Dr. Klippel says there is room for improvement, she also says she is “thrilled to be at an institution where science is the main tool for improving the care of cancer patients.”
Involved in the development of immunotherapy treatments for multiple myeloma, Dr. Klippel is focused on cellular therapy, with the goal of evaluating a combination of approaches to improve outcomes.
“In my lifetime, I hope to see more effective and less toxic therapies… they are becoming more of the rule in oncology,” she says. “I hope to see this trend for all cancers. There is more knowledge about the biology and diversity of an individual cancer. With newer and more affordable technology, we will be able to characterize, with exquisite detail, each case. This will guide us in terms of treatment and will hopefully improve outcomes.”